ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,408.90
0.36%
S&P ASX All Technology
3,893.00
0.20%
Brent Oil
77.625
0.00%
US Dollar vs AUD
1.58353
0.00%
Bitcoin
104,922.25
0.18%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Alpha Tau Medical Ltd (DRTS) Share Price

Alpha Tau Medical Ltd

Alpha Tau Medical Ltd (DRTS)

NASDAQ
4.03
-0.03
(-0.74%)
Closed 26 January 8:00AM
Delayed by 15 minutes
4.10
0.07
(1.74%)
After Hours: 11:59AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
4.03
Bid
3.63
Offer
4.19
Volume
133,087
3.82 Day's Range 4.12
1.75 52 Week Range 4.12
Market Cap
280.773M
Previous Close
4.06
Open
4.08
Last Trade
2
@
3.83
Last Trade Time
Financial Volume
US$ 536,777
VWAP
4.0333
Average Volume (3m)
67,425
Shares Outstanding
69,670,612
Dividend Yield
-
PE Ratio
-9.80
Earnings Per Share (EPS)
-0.42
Revenue
-
Net Profit
-29.16M

About Alpha Tau Medical Ltd

Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.alphatau.com
Headquarters
Jerusalem, Jerusalem, Isr
Founded
-
Alpha Tau Medical Ltd is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker DRTS. The last closing price for Alpha Tau Medical was US$4.06. Over the last year, Alpha Tau Medical shares have traded in a share price range of US$ 1.75 to US$ 4.12.

Alpha Tau Medical currently has 69,670,612 shares in issue. The market capitalisation of Alpha Tau Medical is US$282.86 million. Alpha Tau Medical has a price to earnings ratio (PE ratio) of -9.80.

Ask ADVFN Intelligence (AI)

DRTS Latest News

More News

Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day

JERUSALEM, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

19 December 2024
GlobeNewswire Inc.

Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor

JERUSALEM, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW), ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha...

18 December 2024
GlobeNewswire Inc.

Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference

JERUSALEM, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

12 December 2024
GlobeNewswire Inc.

Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium

JERUSALEM, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

07 December 2024
GlobeNewswire Inc.

Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

- Alpha DaRT® accepted into the prestigious Total Product Life Cycle Advisory Program (TAP) of the FDA, to accelerate market access to the Alpha DaRT® for patients with recurrent glioblastoma...

20 November 2024
GlobeNewswire Inc.

Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference

JERUSALEM, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

14 November 2024
GlobeNewswire Inc.

Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme

JERUSALEM, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-emitters cancer therapy Alpha...

21 October 2024
GlobeNewswire Inc.

Alpha Tau Treats First Patient with Recurrent Lung Cancer

JERUSALEM, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

10 October 2024
GlobeNewswire Inc.

Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC

JERUSALEM, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

20 September 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

22 August 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.133.333333333333.94.123.875900383.98537127CS
40.93303.14.123.011217123.6742101CS
121.6972.22222222222.344.122.14674253.25631479CS
261.9795.63106796122.064.121.93425482.94416422CS
521.0334.333333333334.121.75388162.80044197CS
156-7.52-65.108225108211.5520.651.75937948.68397589CS
260-7.52-65.108225108211.5520.651.75937948.68397589CS

DRTS - Frequently Asked Questions (FAQ)

What is the current Alpha Tau Medical share price?
The current share price of Alpha Tau Medical is US$ 4.03
How many Alpha Tau Medical shares are in issue?
Alpha Tau Medical has 69,670,612 shares in issue
What is the market cap of Alpha Tau Medical?
The market capitalisation of Alpha Tau Medical is USD 282.86M
What is the 1 year trading range for Alpha Tau Medical share price?
Alpha Tau Medical has traded in the range of US$ 1.75 to US$ 4.12 during the past year
What is the PE ratio of Alpha Tau Medical?
The price to earnings ratio of Alpha Tau Medical is -9.8
What is the reporting currency for Alpha Tau Medical?
Alpha Tau Medical reports financial results in USD
What is the latest annual profit for Alpha Tau Medical?
The latest annual profit of Alpha Tau Medical is USD -29.16M
What is the registered address of Alpha Tau Medical?
The registered address for Alpha Tau Medical is KIRYAT HAMADA ST. 5, JERUSALEM, JERUSALEM, 9777605
What is the Alpha Tau Medical website address?
The website address for Alpha Tau Medical is www.alphatau.com
Which industry sector does Alpha Tau Medical operate in?
Alpha Tau Medical operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
EVAXEvaxion Biotech AS
US$ 5.99
(64.56%)
55.41M
ELABPMGC Holdings Inc
US$ 3.0901
(56.07%)
76.48M
PCLAPicoCELA Inc
US$ 4.60
(49.35%)
3.75M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
GODNUGolden Star Acquisition Corporation
US$ 3.11
(-75.82%)
17.51k
GODNGolden Star Acquisition Corporation
US$ 2.93
(-65.67%)
902.76k
NXTTNext Technology Holding Inc
US$ 1.37
(-54.93%)
2.56M
SGLYSingularity Future Technology Ltd
US$ 1.625
(-38.45%)
917.77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90.11
(-38.07%)
8
ACONAclarion Inc
US$ 0.0557
(28.94%)
811.91M
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
RIMEAlgorhythm Holdings Inc
US$ 0.0357
(4.69%)
284.97M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
NVDANVIDIA Corporation
US$ 142.62
(-3.12%)
232.88M

DRTS Discussion

View Posts
PonkenPlonken PonkenPlonken 5 days ago
Its relevant for people that are new to the board. Always look at how they started.
cliffnotes. Keep in mind the company is based in Jerusalem.

- The transaction represents an implied pro forma equity value of approximately $1 billion and is expected to provide up to $367 million in gross proceeds, including up to $275 million of cash held in the trust account of Healthcare Capital Corp. (Nasdaq: HCCC) and a $92 million PIPE.

- Citigroup is acting as financial advisor to Alpha Tau. Citigroup, Piper Sandler, and Cantor Fitzgerald are acting as joint placement agents on the PIPE. Cantor Fitzgerald is acting as a capital markets advisor to HCC. Value Base M&A Ltd. is also acting as financial advisor on the transaction.

Latham & Watkins LLP and Meitar | Law Offices are acting as legal advisors to Alpha Tau. Ellenoff Grossman & Schole LLP and FBC & Co. are acting as legal advisors to HCC. Winston & Strawn LLP is acting as legal advisor to the placement agents.
👍️0
theswordman theswordman 6 days ago
You posted the same link 1 month ago.

Also that article/link is 3 1/2 years old
👍️0
PonkenPlonken PonkenPlonken 6 days ago
coming to life
https://www.alphatau.com/single-post/alpha-tau-healthcare-capital-corp-to-combine-and-create-a-1-billion-publicly-traded-company
👍️0
TrendTrade2016 TrendTrade2016 1 week ago
DRTS GOOD BIOS WITH A STRONG PIPELINE WILL DO OKAY IN 2025...SPEC BIOS WILL GET WIPED OUT!
👍️0
TrendTrade2016 TrendTrade2016 1 week ago
DRTS BREAKING 4 BUCKS ON ITS WAY TO 4.59 TARGET...WEEKLY BREAK OUT
👍️0
Acme Investments Acme Investments 2 weeks ago
👇 This is what happens when you show up after the stock moves!! Headed back to 2's then maybe back up!!
👍️0
Acme Investments Acme Investments 2 weeks ago
Now you want to be the Riddler?? Lol!! I'm busy mastering my universe!!
👍️0
Acme Investments Acme Investments 2 weeks ago
You can get did you put over 10K worth of confidence in it!!
👍️0
theswordman theswordman 2 weeks ago
Can I get part of that "no post before JAN" bet ??
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
WHEN WE ARE OUT OF THIS MARKET CHOP...DO YOU KNOW WHAT THE CHOP IS.....GOOGLE IT..YA MIGHT LEARN SOMETHING.
👍️0
Acme Investments Acme Investments 2 weeks ago
I put it on my watch list!! 4.50 when?? This year, month, week?? I'm on to you!! Another empty prediction!!
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
WEIRDO...WATCH AND LEARN T0 4.50
👍️0
Acme Investments Acme Investments 2 weeks ago
I bet you don't have a post before January!! My name is Acme and I approve this message!!
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
DRTS...ADDING DIPS...FAVO BIO FOR 2025
👍️0
theswordman theswordman 2 weeks ago
👍️0
PonkenPlonken PonkenPlonken 3 weeks ago
here it comes
👍️0
TrendTrade2016 TrendTrade2016 3 weeks ago
DRTS HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 3 weeks ago
DRTS NEW BIO BEAST AS WEEKLY SETS UP FOR BREAK OUT
👍️0
theswordman theswordman 3 weeks ago
Investor update day


👍️0
PonkenPlonken PonkenPlonken 1 month ago
https://www.ourcrowd.com/startup-news/alpha-tau-100-complete-response-rate-in-skin-cancer-trial?
might become SOC in inoperable tumors - super tech - revolutionize radio
👍️0
PonkenPlonken PonkenPlonken 1 month ago
has a lot of critical readouts coming soon - see below
neglected and forgotten...
👍️0
PonkenPlonken PonkenPlonken 1 month ago
https://www.alphatau.com/single-post/alpha-tau-healthcare-capital-corp-to-combine-and-create-a-1-billion-publicly-traded-company
👍️0
PonkenPlonken PonkenPlonken 2 months ago
Great Israeli company -- coming to life ahead of a few readouts
👍️0
theswordman theswordman 2 months ago
3rd QTR update: 2+ years op cash. Trial expansion.
FDA accepted for TAP--Total Product Life Cycle Advisory Program (TAP)
FDA approval of an Investigational Device Exemption (IDE) application for cSCC

https://www.alphatau.com/single-post/alpha-tau-medical-announces-third-quarter-2024-financial-results-and-provides-corporate-update
👍️0
theswordman theswordman 3 months ago
AlphaTau into the FDAs TPLC program: https://www.alphatau.com/single-post/alpha-tau-announces-acceptance-into-fda-s-total-product-life-cycle-advisory-program-to-accelerate-ma

Here is link that explains what that program helps with : https://www.fda.gov/medical-devices/how-study-and-market-your-device/total-product-life-cycle-advisory-program-tap
👍️0
theswordman theswordman 4 months ago
1st lung cancer patient treated--https://www.alphatau.com/single-post/alpha-tau-treats-first-patient-with-recurrent-lung-cancer

“The treatment makes use of bronchoscopic endobronchial ultrasound to insert the Alpha DaRT sources.

examining its application to an organ such the lung, given its proximity to vital healthy organs, may hopefully open new doors to a global population of patients with otherwise poor treatment options
👍️0
theswordman theswordman 4 months ago
Emory Univ wants another trial for subpopulation

https://www.alphatau.com/single-post/fda-approval-of-ide-to-initiate-multi-center-investigator-initiated-study-of-alpha-dart-in-immunoco
👍️0
theswordman theswordman 4 months ago
The big boys are correct. Just a little off ontheir delivery and MOA

https://www.cnbc.com/2024/09/16/radiopharmaceuticals-race-heats-up-as-drugmakers-chase-novartis.html
👍️0
theswordman theswordman 5 months ago
2nd qtr update

https://www.alphatau.com/single-post/alpha-tau-medical-announces-second-quarter-2024-financial-results-and-provides-corporate-update
👍️0
theswordman theswordman 7 months ago
Atlanta TV discussing AlphaDart trial at Emory Univ.

https://www.atlantanewsfirst.com/2024/06/25/emory-doctor-hopeful-about-clinical-trial-new-skin-cancer-treatment/

https://clinicaltrials.gov/study/NCT05323253?term=alpha%20tau&intr=alpha%20dart&page=2&rank=20#study-overview
👍️0
theswordman theswordman 7 months ago
Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers

https://www.alphatau.com/single-post/alpha-tau-announces-publication-in-cancers-journal-of-long-term-safety-and-efficacy-data-in-multiple
👍️0
Monksdream Monksdream 7 months ago
DRTS under $3
👍️0
theswordman theswordman 8 months ago
https://www.alphatau.com/single-post/alpha-tau-medical-announces-first-quarter-2024-financial-results-and-provides-corporate-update
👍️0
theswordman theswordman 8 months ago
https://www.alphatau.com/single-post/alpha-tau-announces-alpha-dart-treatment-of-first-patient-with-liver-metastases-of-colorectal-cancer
👍️0
theswordman theswordman 9 months ago
Bassett is one of two Alpha DaRT trial sites in New York State, the other being Memorial Sloan Kettering Cancer Center in New York City.

https://www.allotsego.com/skin-cancer-treatment-trials-open/
👍️0
theswordman theswordman 9 months ago
March Investor Deck

https://www.alphatau.com/_files/ugd/89ab89_701f2ad74a4c4684b223cb427cf79506.pdf
👍️0
theswordman theswordman 1 year ago
AlphaTau--Sidoti Conference

https://www.alphatau.com/single-post/alpha-tau-to-participate-in-sidoti-small-cap-conference

OR

https://www.meetmax.com/sched/event_98459/conference_presentations.html?bank_access=0&event_id=98459

This is from 07 DEC (THURS) @ 9:15 AM
👍️0
theswordman theswordman 1 year ago
Pancreatic Cancer Trial--early results
https://www.alphatau.com/single-post/highly-promising-interim-results-of-alpha-dart-treatment-of-advanced-pancreatic-cancer
👍️0
theswordman theswordman 1 year ago
Japan’s Pharmaceuticals and Medical Devices Agency (“PMDA”) has accepted Alpha Tau’s submission requesting shonin pre-market approval of Alpha DaRT in patients with recurrent head & neck cancer

https://www.alphatau.com/single-post/atm-submits-to-japanese-pmda-for-pre-market-approval-of-alpha-dart-for-recurrent-head-neck-cancer
👍️0
theswordman theswordman 1 year ago
CORP UPDATE

https://finance.yahoo.com/news/alpha-tau-medical-announces-third-213000260.html?.tsrc=rss
👍️0
theswordman theswordman 1 year ago
New video presentation. Updates about Hahn@SAB. New manuf facility.

👍️0
theswordman theswordman 1 year ago
Alpha Tau adds another manuf facility in U.S. So this is certainly getting ahead (cart before the horse??)
https://www.alphatau.com/single-post/atm-enters-into-long-term-lease-of-site-in-new-hampshire-for-second-u-s-manufacturing-facility

The Hudson site promises to be larger than our existing Lawrence site, and is expected to support our goals of materially scaling up capacity as well as achieving manufacturing redundancy
👍️0
theswordman theswordman 1 year ago
Hahn joins Science Advisor Board

https://www.marketscreener.com/quote/stock/ALPHA-TAU-MEDICAL-LTD-134583875/news/Alpha-Tau-Medical-Ltd-Announces-Stephen-M-Hahn-Joins-Scientific-Advisory-Board-45136482/
👍️0
theswordman theswordman 1 year ago
Latest DRTS presentation
👍️0
theswordman theswordman 1 year ago
2nd patient treated for inoperable pancreatic cancer. 1St was in Montreal

https://www.globenewswire.com/news-release/2023/09/14/2743253/0/en/Alpha-Tau-Treats-First-Patient-with-Advanced-Inoperable-Pancreatic-Cancer-at-Israel-s-Hadassah-Medical-Center.html
👍️0
Awl416 Awl416 1 year ago
Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT
👍️0
theswordman theswordman 2 years ago
New K O L event

👍️0
theswordman theswordman 2 years ago
CORP UPDATE

https://www.alphatau.com/single-post/alpha-tau-medical-announces-first-quarter-2023-financial-results-and-provides-corporate-update
👍️0
theswordman theswordman 2 years ago
With our Breakthrough Device Designation for the treatment of certain patients with squamous cell carcinoma, we look forward to swift accrual into our U.S. pivotal ReSTART trial, with the goal of bringing the Alpha DaRT closer to availability for patients as quickly as possible."

The results of the trial demonstrated that the treatment was successfully delivered to ten of ten patients, with a 100% CR observed at 12 and 24 weeks,

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2804784
👍️0
theswordman theswordman 2 years ago
New buy rating

https://beststocks.com/alpha-tau-medical-receives-buy-rating-and-hig/
👍️0

Your Recent History

NASDAQ
DRTS
Alpha Tau Medical
TG
A282U9
Nationale Nederlanden Ba...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads